iifl-logo-icon 1

Shree Ganesh Remedies Ltd Board Meeting

825.1
(-3.46%)
Jul 4, 2024|03:41:00 PM

Shree Ganesh Rem CORPORATE ACTIONS

06/07/2023calendar-icon
05/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting1 Jun 202421 May 2024
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended on March 31 2024 along with the Audit Report for the corresponding period Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/06/2024 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) for the quarter and the financial year ended March 31, 2024 (As per BSE Announcement Dated on 30/05/2024) Outcome of Board Meeting (As Per BSE Announcement Dated on: 01/06/2024)
Board Meeting15 Mar 202415 Mar 2024
Outcome of Board meeting Appointment of Company Secretary and Compliance Officer
Board Meeting4 Mar 20244 Mar 2024
Updation of Registered Office Address of the Company
Board Meeting12 Feb 20245 Feb 2024
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2023 Outcome of Board Meeting (As per BSE Announcement Dated on 12/02/2024)
Board Meeting25 Jan 202419 Jan 2024
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve first and final call on the outstanding 840471 (Eight Lakhs Forty Thousand Four Hundred Seventy-One) partly paidup equity shares of the Company. Outcome of the Meeting of the Rights Issue Committee. (As Per BSE Announcement dated on 25.01.2024)
Board Meeting10 Nov 20231 Nov 2023
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30 2023 Outcome of Board Meeting Results- Financial Results September 30, 2023 (As Per BSE Announcement Dated on 10/11/2023) Newspaper Advertisement for Financial Results (As Per BSE Announcement Dated on 13/11/2023)
Board Meeting31 Jul 202322 Jul 2023
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2023 SHREE GANESH REMEDIES LIMITED has informed BSE about Board Meeting to be held on 31 Jul 2023 to consider financial statements for the period ended June 2023. Financial results. (As Per BSE Announcement Dated on 25.07.2023) Outcome of Board Meeting The Appointment of M/s Bansi S. Mehta and Co, Chartered Accountants as Statutory Auditor of the Company for a term of 5 years, subject to approval of members in ensuing Annual General Meeting (As Per BSE Announcement dated on 31.07.2023)

Shree Ganesh Rem: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.